n,n-dimethylarginine has been researched along with Infarction, Middle Cerebral Artery in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atzler, D; Böger, RH; Choe, CU; Gelderblom, M; Gerloff, C; Leypoldt, F; Magnus, T; Schwedhelm, E; Sydow, K; von Leitner, EC | 1 |
| Bode-Böger, SM; Doehner, W; Ebinger, M; Endres, M; Kung, T; Liman, T; Martens-Lobenhoffer, J; Sandek, A; Scherbakov, N; Turhan, G; von Haehling, S | 1 |
2 other study(ies) available for n,n-dimethylarginine and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Dimethylarginine dimethylaminohydrolase-1 transgenic mice are not protected from ischemic stroke.
Topics: Amidohydrolases; Animals; Arginine; Brain; Endothelium, Vascular; Genotype; Infarction, Middle Cerebral Artery; Ischemia; Male; Mice; Mice, Transgenic; Models, Biological; Nitric Oxide; Stroke | 2009 |
Endothelial dysfunction of the peripheral vascular bed in the acute phase after ischemic stroke.
Topics: Aged; Analysis of Variance; Arginine; Biomarkers; Blood Pressure; Case-Control Studies; Endothelium, Vascular; Female; Fingers; Forearm; Germany; Heart Failure; Humans; Hyperemia; Infarction, Middle Cerebral Artery; Linear Models; Male; Middle Aged; Plethysmography; Severity of Illness Index; Time Factors; Up-Regulation; Vasodilation | 2012 |